B. Riley Wealth Advisors’s CorMedix CRMD Stock Holding History

B. Riley Wealth Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,850	Closed	-$42.7K	–	1538
2023 Q2	$42.7K	Hold	11,850	–	–	﹤0.01%	1490
2023 Q1	$44.5K	Hold	11,850	–	–	﹤0.01%	1444
2022 Q4	$45.4K	Hold	11,850	–	–	﹤0.01%	1417
2022 Q3	$30K	Hold	11,850	–	–	﹤0.01%	1403
2022 Q2	$43K	Hold	11,850	–	–	﹤0.01%	1176
2022 Q1	$59K	Hold	11,850	–	–	﹤0.01%	1329
2021 Q4	$49K	Hold	11,850	–	–	﹤0.01%	1376
2021 Q3	$74K	Hold	11,850	–	–	﹤0.01%	1354
2021 Q2	$108K	Buy	+11,850	New	+$94.3K	﹤0.01%	1305

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

B. Riley Wealth Advisors's CRMD Position: Q3 2023 in Review

B. Riley Wealth Advisors sold out of CorMedix (CRMD) in Q3 2023, closing a stake of 11,850 shares — an estimated $42.7K sold.

B. Riley Wealth Advisors first reported a position in CRMD in Q2 2021 and held it in 9 quarters. The position peaked at $108K in Q2 2021. 92 funds tracked by Wall St. Rank hold CRMD as of Q3 2023.

B. Riley Wealth Advisors reported no remaining CorMedix position as of Q3 2023 after selling out during the quarter.
B. Riley Wealth Advisors sold 11,850 CorMedix shares in Q3 2023, an estimated $42.7K.
B. Riley Wealth Advisors first reported a position in CorMedix in Q2 2021 and held it in 9 quarters.
B. Riley Wealth Advisors's CorMedix position peaked at $108K in Q2 2021.
92 funds tracked by Wall St. Rank held CorMedix as of Q3 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2023, filed 1 Dec 2023.